Abattis Bioceuticals (C.ATT) bumps 5% on signing partnership LOI with Tranzbyte
March 21, 2014 at 11:49 AM EDT
Abattis Bioceuticals (C.ATT) inks letter of intent with Tranzbyte for strategic partnership and shares climb 5%
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.